State-of-the-Art Review: Hepatitis C

Hepatitis C virus (HCV) infection remains a major cause of chronic liver disease and premature mortality worldwide. The World Health Organization and US Department of Health and Human Services have committed to eliminating HCV infection as a major public health threat by 2030, as defined by a 90% reduction in incidence of new HCV infections and 65% reduction in mortality from a 2015 baseline. To help to achieve HCV elimination, it will be necessary to increase HCV screening and increase uptake of HCV treatment, particularly within primary care, correctional, and substance use treatment settings. In this review, we provide strategies for healthcare providers to implement in their practice to enhance patients' completion of the steps of the HCV care cascade. Improving successful completion of each step of the cascade will help alleviate the burden of HCV infection and make the 2030 HCV elimination goals a reality.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-04-23
DOI
https://doi.org/10.1093/cid/ciaf334
Citations
2
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
2.64
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

State-of-the-Art Review: Hepatitis C

Oluwaseun O Falade-Nwulia, Stacey Trooskin, H. Nina Kim, Andrew Aronsohn et al.
2 citations
Clinical Infectious Diseases
Hepatitis C virus research
2.64
article

State-of-the-Art Review: Hepatitis C

Oluwaseun O Falade-Nwulia, Stacey Trooskin, H. Nina Kim, Andrew Aronsohn, Jennifer C. Price, Vincent Lo Re, Matty Zimmerman, Jessie Torgersen, Debika Bhattacharya
article en
2 citations

Abstract

Hepatitis C virus (HCV) infection remains a major cause of chronic liver disease and premature mortality worldwide. The World Health Organization and US Department of Health and Human Services have committed to eliminating HCV infection as a major public health threat by 2030, as defined by a 90% reduction in incidence of new HCV infections and 65% reduction in mortality from a 2015 baseline. To help to achieve HCV elimination, it will be necessary to increase HCV screening and increase uptake of HCV treatment, particularly within primary care, correctional, and substance use treatment settings. In this review, we provide strategies for healthcare providers to implement in their practice to enhance patients' completion of the steps of the HCV care cascade. Improving successful completion of each step of the cascade will help alleviate the burden of HCV infection and make the 2030 HCV elimination goals a reality.

Clinical Infectious DiseasesVol. 81(2)
Penn Presbyterian Medical Center (US), Johns Hopkins University (US), University of California, Los Angeles (US), University of California, San Francisco (US), University of Washington (US), Johns Hopkins Medicine (US), Mazzoni Center (US), University of Illinois Chicago (US), University of Chicago (US), Presbyterian Medical Center (KR), University of Pennsylvania (US)
Openalex Percentile: Top 9%
Hepatitis C virus research
2.64
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

State-of-the-Art Review: Hepatitis C — Oluwaseun O Falade-Nwulia, Stacey Trooskin, et al. · Clinical Infectious Diseases (2025) | TGRS Research Map | TGRS